TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18541764

Group type: EXPERIMENTAL
Intervention: Malaria rapid diagnostic tests (RDTs) in high transmission district
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Malaria rapid diagnostic tests (RDTs) in low transmission district
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adherence to revised clinical practices with RDTs
Number of subjects: 0
Study: 15790990

Group type: EXPERIMENTAL
Intervention: Coughing up phlegm in winter mornings
Number of subjects: 14458

Group type: EXPERIMENTAL
Intervention: Phlegm at any time of the day in winter
Number of subjects: 14458

Group type: EXPERIMENTAL
Intervention: Wheeze or whistling from the chest
Number of subjects: 14458
Study: 11788634

Group type: EXPERIMENTAL
Intervention: Raloxifene hydrochloride (RLX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study: 9873157

Group type: EXPERIMENTAL
Intervention: Older stroke patients (over 75 years)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Younger stroke patients (up to 75 years)
Number of subjects: 296
Study: 7781864

Group type: EXPERIMENTAL
Intervention: Triptorelin (n = 30)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Danazol (n = 25)
Number of subjects: 55
Study: 1754636

Group type: EXPERIMENTAL
Intervention: Auditory stimulation during each REM sleep episode (Group R)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Auditory stimulation at the end of each REM sleep episode (Group NR)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Auditory stimulation during each REM sleep period (Group D)
Number of subjects: 3
Study: 7200653

Group type: EXPERIMENTAL
Intervention: Topical instillation of adriamycin
Number of subjects: 0
Study: 31119610

Group type: EXPERIMENTAL
Intervention: Provider self-disclosure
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Provider-patient race concordance (Black concordant dyad)
Number of subjects: 882
Study: 27333382

Group type: EXPERIMENTAL
Intervention: Vitamin E (15 mg/kg/day for 12 months)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 46
Study: 27577267

Group type: EXPERIMENTAL
Intervention: Family psychoeducation (four sessions of manualized family psychoeducation)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Social support (four sessions in a social support group led by a health care professional)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Family psychoeducation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Social support
Number of subjects: 100
Study: 24165473

Group type: EXPERIMENTAL
Intervention: Laparoscopic bridging
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open Rives repair
Number of subjects: 0
Study: 21233492

Group type: EXPERIMENTAL
Intervention: Optical laryngoscope
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rigid laryngoscope
Number of subjects: 60
Study: 19145529

Group type: EXPERIMENTAL
Intervention: Airtraq
Number of subjects: 30

Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 30
Study: 17720098

Group type: EXPERIMENTAL
Intervention: Gamma tocopherol (308 mg) and DHA (800 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 15161110

Group type: EXPERIMENTAL
Intervention: Protease supplementation (two tablets containing 325 mg pancreatic enzymes, 75 mg trypsin, 50 mg papain, 50 mg bromelain, 10 mg amylase, 10 mg lipase, 10 mg lysozyme, 2 mg chymotrypsin) four times a day for 4 days starting 1 day before exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11800415

Group type: EXPERIMENTAL
Intervention: Trimetazidine 20 mg orally every 8 hours during hospitalization
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (conventional treatment only)
Number of subjects: 55
Study: 9654632

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 35

Group type: COMPARATOR
Intervention: No TPN
Number of subjects: 35
Study: 7979533

Group type: EXPERIMENTAL
Intervention: Passive smoking exposure (measured by urinary cotinine concentration)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Passive smoking exposure (measured by parental smoking)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (N=51)
Number of subjects: 57
Study: 2610721

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 200 mg naftidrofuryl
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 10
Study: 30647436

Group type: EXPERIMENTAL
Intervention: 250 mg phospholipid curcumin, one capsule per day for 8 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 29061728

Group type: EXPERIMENTAL
Intervention: Coupler implantation and continuing previous pharmacotherapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Previous treatment alone
Number of subjects: 39
Study: 26867335

Group type: EXPERIMENTAL
Intervention: Dual cycle and dual channel treatment (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional single cycle treatment (Group A)
Number of subjects: 60
Study: 23280147

Group type: EXPERIMENTAL
Intervention: Explicit pre-training instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no explicit pre-training instruction)
Number of subjects: 0
Study: 21931204

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg, one tablet every 6 hours for three days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 18240965

Group type: EXPERIMENTAL
Intervention: ENF + OB
Number of subjects: 100

Group type: COMPARATOR
Intervention: OB
Number of subjects: 100
Study: 16644432

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiographic recordings of mitral annulus motion
Number of subjects: 24
Study: 12801493

Group type: EXPERIMENTAL
Intervention: Auricular therapy using magnetic pearls
Number of subjects: 15
Study: 10826459

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily for 5 days followed by 400 mg twice daily for 5 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily for 10 days
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both celecoxib and naproxen
Number of subjects: 29
Study: 8925979

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam
Number of subjects: 56

Group type: COMPARATOR
Intervention: Ampicillin and Gentamicin
Number of subjects: 56
Study: 2053097

Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Psoas compartment block with additional inhalation anaesthesia
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Psoas compartment block
Number of subjects: 196
Study: 7032347

Group type: EXPERIMENTAL
Intervention: Fentanyl 5 microgram/kg body weight before induction with thiopentone and suxamethonium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no fentanyl)
Number of subjects: 0
Study: 31776637

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg once every 6 months)
Number of subjects: 2850

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 2850

Group type: COMPARATOR
Intervention: Bisphosphonate (oral alendronate, risedronate, ibandronate, or intravenous zoledronic acid)
Number of subjects: 2850

Group type: COMPARATOR
Intervention: Denosumab and Bisphosphonate
Number of subjects: 2850
Study: 31014283

Group type: EXPERIMENTAL
Intervention: LASIK with 0.02% MMC application for 10 seconds
Number of subjects: 68

Group type: COMPARATOR
Intervention: LASIK without MMC application
Number of subjects: 68
Study: 28780626

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate (HoLEP)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (diagnostic cystoscopy)
Number of subjects: 150
Study: 25805217

Group type: EXPERIMENTAL
Intervention: Dissonance-based body image intervention delivered by undergraduate students
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: All participants (both groups)
Number of subjects: 62
Study: 23110355

Group type: EXPERIMENTAL
Intervention: Short integrated study skills programme (SSP)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard academic support (Control)
Number of subjects: 84
Study: 21318315

Group type: EXPERIMENTAL
Intervention: Local heat (LH) application for 15 min
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control period (no heat application)
Number of subjects: 9
Study: 19239950

Group type: EXPERIMENTAL
Intervention: Detection of EBV LMP-1 gene in cervical metastatic lymph nodes
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Detection of EBV LMP-1 gene in nasopharyngeal biopsies
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Detection of EBV LMP-1 gene in metastatic lymph nodes of NPC
Number of subjects: 52

Group type: COMPARATOR
Intervention: Comparison with other head and neck carcinomas and tonsillar specimens
Number of subjects: 52
Study: 17971587

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy
Number of subjects: 444

Group type: COMPARATOR
Intervention: Standard-timing RT at week 9
Number of subjects: 444

Group type: COMPARATOR
Intervention: Chemotherapy and RT during induction (up-front RT)
Number of subjects: 444

Group type: COMPARATOR
Intervention: No RT at all (protocol violation)
Number of subjects: 444
Study: 15368110

Group type: EXPERIMENTAL
Intervention: Montelukast sodium (10 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11576078

Group type: EXPERIMENTAL
Intervention: Levocetirizine (5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9519853

Group type: EXPERIMENTAL
Intervention: SAIB (sucrose acetate isobutyrate) ingestion at a dose of 20 mg/kg body weight for 14 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (gum arabic/water emulsion without SAIB)
Number of subjects: 27
Study: 8074599

Group type: EXPERIMENTAL
Intervention: Patient-carried prompt card
Number of subjects: 44

Group type: COMPARATOR
Intervention: Computer-generated prompt
Number of subjects: 44
Study: 2801555

Group type: EXPERIMENTAL
Intervention: Streptokinase treatment
Number of subjects: 368

Group type: COMPARATOR
Intervention: Anticoagulant therapy (placebo group)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Proximal left anterior descending coronary artery affected (Streptokinase)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Proximal left anterior descending coronary artery affected (Anticoagulant therapy)
Number of subjects: 368
Study: 822858

Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) injection
Number of subjects: 5

Group type: COMPARATOR
Intervention: Nicotinic acid injection
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 5
Study: 31604146

Group type: EXPERIMENTAL
Intervention: Dietary nitrate supplementation (beetroot-based high-nitrate supplement)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (low nitrate 'placebo')
Number of subjects: 28
Study: 30728311

Group type: EXPERIMENTAL
Intervention: Submandibular botulinum neurotoxin type A (BoNT‐A)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Submandibular duct ligation (2‐DL)
Number of subjects: 53
Study: 29137842

Group type: EXPERIMENTAL
Intervention: Cetrozole (1.98 μg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: TMD-322 (1.98 μg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Anastrozole (1.98 μg)
Number of subjects: 6
Study: 25595351

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser photocoagulation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Liquid paraffin plus antiseptic cream
Number of subjects: 80
Study: 23219861

Group type: EXPERIMENTAL
Intervention: Pimozide augmentation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 21642511

Group type: EXPERIMENTAL
Intervention: Low-dose PSW treatment (power of 14.5 W, treatment duration of 19 minutes, total energy of 17 kJ)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: High-dose PSW treatment (power of 14.5 W, treatment duration of 38 minutes, total energy of 33 kJ)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 121
Study: 18804555

Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg q.d.)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Vitamin E (800 IU q.d.)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study: 17303443

Group type: EXPERIMENTAL
Intervention: Active treatment (capacitively coupled, pulsed electrical stimulation device)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 58
Study: 15219276

Group type: EXPERIMENTAL
Intervention: (R,R)[123I]-I-QNB with normalization to cerebellum
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: (R,R)[123I]-I-QNB with normalization to whole brain
Number of subjects: 25
Study: 11236229

Group type: EXPERIMENTAL
Intervention: Combination gel (5% benzoyl peroxide and 1% clindamycin)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Benzoyl peroxide
Number of subjects: 287

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 287
Study: 9672013

Group type: EXPERIMENTAL
Intervention: Patients with cardiac sources of embolism
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Patients with severe carotid obstructions
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Patients with carotid obstructive disease
Number of subjects: 800
Study: 7973967

Group type: EXPERIMENTAL
Intervention: Surgical stabilization and fusion
Number of subjects: 113

Group type: COMPARATOR
Intervention: Laminectomy alone
Number of subjects: 113

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 113
Study: 2511136

Group type: EXPERIMENTAL
Intervention: vasopressin (0.4 to 0.8 unit per min for 12 hr) associated with transdermal nitroglycerin (10 mg in 24 hr)
Number of subjects: 69

Group type: COMPARATOR
Intervention: vasopressin-placebo
Number of subjects: 69
Study: 1015360

Group type: EXPERIMENTAL
Intervention: Sulfaisomidine administered on an empty stomach
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sulfaisomidine administered with a standardized breakfast
Number of subjects: 8
Study: 31519301

Group type: EXPERIMENTAL
Intervention: Capsaicin 8% cream (CPS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo cream (PLA)
Number of subjects: 40
Study: 29578603

Group type: EXPERIMENTAL
Intervention: Lay health educator (LHE) intervention with 2 education sessions and 2 telephone follow-up calls on CRC screening plus a CRC brochure
Number of subjects: 304

Group type: COMPARATOR
Intervention: Attention control with 2 lectures and 2 follow-up calls on nutrition and physical activity plus a CRC brochure
Number of subjects: 304
Study: 26658524

Group type: EXPERIMENTAL
Intervention: Task-oriented exercise with mirror therapy (EG)
Number of subjects: 20
Study: 24447460

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) delivered by junior professional or para-professional mental health workers
Number of subjects: 440

Group type: COMPARATOR
Intervention: Cognitive Behaviour Therapy (CBT) delivered by highly trained professional therapists
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) and Cognitive Behaviour Therapy (CBT)
Number of subjects: 440
Study: 22475409

Group type: EXPERIMENTAL
Intervention: BP‐NCPAP
Number of subjects: 136

Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 136
Study: 21058475

Group type: EXPERIMENTAL
Intervention: Acupoint injection therapy with compound Danshen injection at Zusanli (ST 36) and Weishu (BL 21) for 2 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Oral administration of Omeprazole for 2 weeks
Number of subjects: 102
Study: 17371590

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 15637764

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with Fuzheng Yiliu decoction
Number of subjects: 60
Study: 12394376

Group type: EXPERIMENTAL
Intervention: Gluten-free diet for at least two years
Number of subjects: 54

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 54
Study: 10454403

Group type: EXPERIMENTAL
Intervention: Combination of a standard smoking cessation programme with nicotine gum and a behavioural weight control programme including a very low energy diet
Number of subjects: 287

Group type: COMPARATOR
Intervention: Control group treated with the identical programme but without the diet
Number of subjects: 287
Study: 8580269

Group type: EXPERIMENTAL
Intervention: GR122311X 200 mg b.d.
Number of subjects: 1620

Group type: EXPERIMENTAL
Intervention: GR122311X 400 mg b.d.
Number of subjects: 1620

Group type: EXPERIMENTAL
Intervention: GR122311X 800 mg b.d.
Number of subjects: 1620

Group type: COMPARATOR
Intervention: Ranitidine hydrochloride 150 mg b.d.
Number of subjects: 1620
Study: 2790864

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulfate (SLS) 34.7 mM
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Zinc citrate 12.0 mM
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combination of zinc citrate (14.4 mM) and SLS (34.7 mM)
Number of subjects: 7
Study: 1262859

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 1
Study: 31556633

Group type: EXPERIMENTAL
Intervention: Schema mindfulness-based cognitive therapy (SMBCT) + treatment as usual (TAU)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Competitive memory therapy (COMET) + treatment as usual (TAU)
Number of subjects: 58
Study: 31171755

Group type: EXPERIMENTAL
Intervention: Eculizumab (monoclonal antibody against complement C5)
Number of subjects: 0
Study: 28147351

Group type: EXPERIMENTAL
Intervention: Ileocecal resection with ileocolonic anastomosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strictureplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endoscopic treatment (balloon dilatation and stenting)
Number of subjects: 0
Study: 25567087

Group type: EXPERIMENTAL
Intervention: Painful tooth stimulation
Number of subjects: 13

Group type: COMPARATOR
Intervention: Tooth stimulation below the sensory threshold (control)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No tooth stimulation (third session)
Number of subjects: 13
Study: 23344116

Group type: EXPERIMENTAL
Intervention: Type 1 knee-ankle-foot orthosis
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Type 2 knee-ankle-foot orthosis
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Type 3 knee-ankle-foot orthosis
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Full-time use of knee-ankle-foot orthoses
Number of subjects: 22
Study: 21288340

Group type: EXPERIMENTAL
Intervention: Exercise intervention including a depression awareness and physical activity training session for care home staff, plus a whole home physical activation programme with twice weekly physiotherapist-led exercise groups for 12 months.
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group receiving only a depression awareness training session for care home staff.
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 78
Study: 18165589

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nicotine 3 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 17082914

Group type: EXPERIMENTAL
Intervention: Aerated rotating drum reactor (RDR) with lifters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aerated rotating drum reactor (RDR) without lifters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soil slurry experiments at N = 0.25 s(‐1)
Number of subjects: 0
Study: 12646431

Group type: EXPERIMENTAL
Intervention: 100 mL of contrast material plus a 50‐mL saline chaser
Number of subjects: 26

Group type: COMPARATOR
Intervention: 150 mL of contrast material
Number of subjects: 26
Study: 11199427

Group type: EXPERIMENTAL
Intervention: Tissue harmonic imaging (THI) sonography
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional sonography
Number of subjects: 25
Study: 9350881

Group type: COMPARATOR
Intervention: WHO‐ORS (Group A)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Plantain flour‐based solution (Group B)
Number of subjects: 238
Study: 8411742

Group type: EXPERIMENTAL
Intervention: Propranolol (dose reducing heart rate by 25%)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Sclerotherapy (intra‐variceal and extra‐variceal injection of ethanolamine oleate)
Number of subjects: 65
Study: 3546687

Group type: EXPERIMENTAL
Intervention: diflunisal
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: phenylbutazone
Number of subjects: 33
Study: 30460348

Group type: EXPERIMENTAL
Intervention: 1-day group (n = 40) with cefozopran (CZOP) given only on the day of surgery
Number of subjects: 82

Group type: COMPARATOR
Intervention: 5-day group (n = 42) with cefozopran (CZOP) given for 5 consecutive days starting on the day of surgery
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 1-day group (n = 40)
Number of subjects: 82

Group type: COMPARATOR
Intervention: 5-day group (n = 42)
Number of subjects: 82
Study: 27072537

Group type: EXPERIMENTAL
Intervention: 3 h group (cumulus cells removed at 3 h after insemination)
Number of subjects: 172

Group type: COMPARATOR
Intervention: 20 h group (cumulus cells removed at 20 h after insemination)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: 3 h group
Number of subjects: 172

Group type: COMPARATOR
Intervention: 20 h group
Number of subjects: 172
Study: 25748876

Group type: EXPERIMENTAL
Intervention: Direct referral to low-dose chest CT (LDCT)
Number of subjects: 493

Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Direct access to LDCT
Number of subjects: 493

Group type: COMPARATOR
Intervention: Fast-track evaluation by chest physician
Number of subjects: 493